E3 PreliminaryPreliminaryPEM not requiredMechanisticPeer-reviewedMachine draft
Beneficial effect of brewers' yeast extract on daily activity in a murine model of chronic fatigue syndrome.
Takahashi, Takashi, Yu, Fei, Zhu, Shi-Jie et al. · Evidence-based complementary and alternative medicine : eCAM · 2006 · DOI
Quick Summary
Researchers gave mice a brewer's yeast extract to see if it could help restore activity levels in a mouse model of ME/CFS. Mice treated with the yeast extract showed significantly better activity levels compared to untreated mice, and the treated mice also had better survival rates. The study suggests that brewer's yeast extract may help by adjusting immune system responses that become imbalanced in ME/CFS.
Why It Matters
This preclinical work provides mechanistic insight into how nutritional interventions may benefit ME/CFS by modulating dysregulated immune responses. If findings translate to humans, brewer's yeast extract could represent an accessible, oral therapeutic option for addressing post-exertional malaise and immune dysfunction.
Observed Findings
- Treated mice showed significantly higher daily running activity in the 2 weeks following the second BA injection compared to untreated controls.
- No mortality occurred in the treated group versus 2 deaths in the control group during the observation period.
- Treated mice demonstrated decreased spleen weight and spleen weight-to-body weight ratio with expanded splenic follicular areas.
- IFN-gamma and IL-10 mRNA expression levels were suppressed in the spleens of treated mice.
- Body weight did not differ between treated and control groups throughout the study.
Inferred Conclusions
- Brewer's yeast extract may provide a protective effect against activity reduction in this CFS model through immune system normalization.
- The immune-modulating properties of BYE may involve suppression of both pro-inflammatory (IFN-gamma) and anti-inflammatory (IL-10) responses.
- The intervention showed survival benefit alongside functional improvement in this model.
Remaining Questions
- Would these results replicate in human ME/CFS patients, and what would be the appropriate dose translation to humans?
- What are the specific active components of brewer's yeast extract responsible for the immunomodulatory effect?
What This Study Does Not Prove
This mouse model study does not prove that brewer's yeast extract will be effective in human ME/CFS patients, as animal models do not fully replicate human disease complexity. The study cannot establish optimal dosing, safety, or efficacy in humans. Findings suggest association between immune normalization and activity improvement, not definitive causation.
Tags
Symptom:Fatigue
Biomarker:CytokinesGene Expression
Phenotype:Infection-Triggered
Method Flag:PEM Not DefinedSmall SampleExploratory Only
Metadata
- DOI
- 10.1093/ecam/nek012
- PMID
- 16550231
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →